$CI · Cigna Group SEC Filings
Position Tracker tracks 12 SEC EDGAR filings for Cigna Group ($CI) from August 6, 2026 through November 5, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 3 Form 8-K current event disclosures, and 6 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$CI 10-Q — Cigna Group
Cigna's top-line growth masks a 23% drop in shareholders' net income as noncontrolling interests and pharmacy costs weigh on results.
$CI 8-K — Cigna Group
A guidance raise plus a new $3B productivity program and long-term 10%-14% EPS CAGR target give investors a concrete growth roadmap.
$CI 8-K — The Cigna Group
The Cigna Group submitted a Current Report on Form 8-K to the SEC on October 9, 2026. The filing discloses an update under Item 5.02, which covers departures of directors or cer…
$CI 8-K — The Cigna Group
On September 30, 2026, The Cigna Group filed a Form 8-K announcing that it would host its Investor Day that same morning, both in person and virtually. The company issued a pres…
$CI 4 — The Cigna Group
The Cigna Group filed a SEC Form 4 on September 8, 2026, disclosing a change in beneficial ownership by Neville Everett, an executive listed as EVP, Special Advisor to the CEO.…
$CI 4 — The Cigna Group
This SEC Form 4 filing reports equity compensation awarded to Brian C. Evanko, the President and Chief Executive Officer of The Cigna Group. On September 1, 2026, Evanko receive…
$CI 144 — The Cigna Group
The Cigna Group filed a Form 144 with the SEC on September 3, 2026, giving notice of a proposed sale of common stock by an officer of the company. The notice covers 617 shares t…
$CI 4 — The Cigna Group
On August 31, 2026, George Kurian, a director of The Cigna Group, reported the acquisition of 108.6642 phantom stock units at a price of $276.08 per unit. According to the filin…
$CI 4 — The Cigna Group
A Form 4 was filed with the SEC on August 20, 2026, reporting transactions by Bryan Holgerson, identified as President, Cigna Healthcare U.S. and EVP, Customer Health Outcomes.…
$CI 4 — The Cigna Group
This SEC filing is a Form 4 statement of changes in beneficial ownership for The Cigna Group, filed by Nicole S. Jones. She is identified as an executive officer of the company,…
$CI 144 — The Cigna Group
The Cigna Group filed a Form 144 with the Securities and Exchange Commission on August 18, 2026. The filing is a notice of a proposed sale of securities by Nicole S. Jones, who…
$CI 4 — The Cigna Group
This Form 4 filing reports changes in beneficial ownership by Nicole S. Jones, an executive officer of Cigna Group listed as EVP, Chief Administrative Officer and Chief Human Re…